1. Challenges of clinical translation in nanomedicine: a qualitative study;Satalkar;Nanomed. Nanotechnol. Biol. Med.,2016
2. Committee for Human Medicinal Products, ICH Topic Q2 (R1) Validation of Analytical Procedures, Note for Guidance, European Medicine Agency, 1995.
3. Committee for Human Medicinal Products, ICH Topic Q1A (R2) Stability Testing of new Drug Substances and Products, Note for Guidance, European Medicine Agency, 2003.
4. Committee for Human Medicinal Products, ICH Topic Q1B Photostability Testing of New Active Substances and Medicinal Products, Note for Guidance, European Medicine Agency, 1998.
5. Committee for Human Medicinal Products, ICH Topic Q3A (R2) Impurities in new Drug Substances, Note for Guidance, European Medicine Agency, 2006.